| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Previous issue > Previous issue



Table of Contents | March, 2022  Vol. 40  No.1 Previous Issue | Next Issue | Archive
In this issue:




Review Article
1 Reviewing the potential role of radiation therapy in gallbladder cancer: an update
Divyesh Kumar, Nali Muni Kiran, Divya Khosla
Radiat Oncol J. 2022;40(1):1-8.   Published online 2022 Jan 25     DOI: https://doi.org/10.3857/roj.2021.00717
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 1
Original Articles
Clinical Investigations
9 Limited field adaptive radiotherapy for glioblastoma: changes in target volume and organ at risk doses
Öznur Şenkesen, Evrim Tezcanlı, Mehmet Ufuk Abacıoğlu, Zeynep Özen, Derya Çöne, Halil Küçücük, Evren Ozan Göksel, Alptekin Arifoğlu, Meriç Şengöz
Radiat Oncol J. 2022;40(1):9-19.   Published online 2022 Mar 28     DOI: https://doi.org/10.3857/roj.2021.00542
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 7  Crossref 6
20 PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung
Radiat Oncol J. 2022;40(1):20-28.   Published online 2022 Mar 25     DOI: https://doi.org/10.3857/roj.2021.00934
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 3  Crossref 4
29 Trends in the use of radiation for meningioma across the United States
Hirsch Matani, Stephen Abel, Alexander Yu, Stephen M. Karlovits, Rodney E. Wegner
Radiat Oncol J. 2022;40(1):29-36.   Published online 2022 Mar 15     DOI: https://doi.org/10.3857/roj.2021.00563
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 3  Crossref 3
37 Optimal positive lymph node ratio showing the benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: an exploratory study using the Surveillance, Epidemiology, and End Results data
Shiho Lee, O Kyu Noh
Radiat Oncol J. 2022;40(1):37-44.   Published online 2022 Mar 22     DOI: https://doi.org/10.3857/roj.2021.00969
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 3  Crossref 2
45 Long-term outcomes of low-dose radiotherapy in Kasabach-Merritt syndrome
Dowook Kim, Jung Yoon Choi, Kyung Taek Hong, Hyoung Jin Kang, Il Han Kim, Joo Ho Lee
Radiat Oncol J. 2022;40(1):45-52.   Published online 2022 Mar 22     DOI: https://doi.org/10.3857/roj.2021.00983
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Crossref 1
Biology contributions
53 Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy
Yeeun Kim, Changhoon Choi, Jee Hyun Park, Won-Gyun Ahn, Sung-Won Shin, Shin-Yeong Kim, Jae Myoung Noh
Radiat Oncol J. 2022;40(1):53-65.   Published online 2022 Feb 23     DOI: https://doi.org/10.3857/roj.2021.00885
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 2  Crossref 2
66 PA1 cells containing a truncated DNA polymerase β protein are more sensitive to gamma radiation
Anutosh Patra, Anish Nag, Anindita Chakraborty, Nandan Bhattacharyya
Radiat Oncol J. 2022;40(1):66-78.   Published online 2022 Mar 29     DOI: https://doi.org/10.3857/roj.2021.00689
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Case Report
79 Radiation therapy in chronic hidradenitis suppurativa: case report
Pitchaya Sakyanun, Thirada Vongvanichvathana, Prasert Lertsanguansinchai
Radiat Oncol J. 2022;40(1):79-85.   Published online 2022 Mar 3     DOI: https://doi.org/10.3857/roj.2021.00570
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 2
Letter to the Editor
86 Comment on “Abscopal effect in the radio and immunotherapy”
François Fabi
Radiat Oncol J. 2022;40(1):86-87.   Published online 2022 Mar 22     DOI: https://doi.org/10.3857/roj.2022.00017
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 1
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 2.3
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Elekta Korea
DAWON MEDAX
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next